Proxinium
Term · Oncology and biomedicine · MLC-T-ONC-007029
A substance being studied in the treatment of certain types of head and neck cancer. Proxinium is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and VB4-845.
| Identifier | MLC-T-ONC-007029 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-EpCAM-Pseudomonas-exotoxin fusion protein; VB4-845 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007029",
"term": "Proxinium",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of certain types of head and neck cancer. Proxinium is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and VB4-845.",
"synonyms": [
"anti-EpCAM-Pseudomonas-exotoxin fusion protein",
"VB4-845"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/proxinium/"
}
Record 13,788 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.